Nanda, Shivani
HUTCHMED (China) Limited (China)
2 papers on CoChatORCID 0000-0001-6358-2392
Most cited papers
- Verified
Larotrectinib in Patients with TRK Fusion-Positive Solid Tumours: A Pooled Analysis of Three Phase 1/2 Clinical Trials
Hong, D. S., DuBois, S. G., Kummar, S., Farago, A. F., Albert, C. M., Rohrberg, K. S., van Tilburg, C. M., Nagasubramanian, R., Berlin, J. D., Federman, N., et al. (2020) · The Lancet Oncology
Sarcoma Diagnosis and TreatmentLung Cancer Treatments and Mutations
Cited by 1,028
- Verified
Fruquintinib versus Placebo in Patients with Refractory Metastatic Colorectal Cancer (FRESCO-2): An International, Multicentre, Randomised, Double-Blind, Phase 3 Study
Dasari, A., Lonardi, S., Garcia-Carbonero, R., Elez, E., Yoshino, T., Sobrero, A., Yao, J., García-Alfonso, P., Kocsis, J., Cubillo Gracian, A., et al. (2023) · The Lancet
Colorectal Cancer Treatments and StudiesAngiogenesis and VEGF in Cancer
Cited by 368
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free